At SGI-DNA, our mission is to develop revolutionary synthetic genomics platforms that accelerate advances in drug discovery, precision medicine, DNA data storage and industrial design; bridging the gap between the digital and biological worlds. Founded in 2014, SGI-DNA was officially spun out of Synthetic Genomics, Inc. (SGI) in March of 2019.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/10/19 | $25,000,000 | Series A |
BroadOak Capital Partners Northpond Ventures  Oxford Finance | undisclosed |
